Table 3 Sensitivity of antigenemia and in upper and lower respiratory-tract specimens at different time point.

From: SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19

Symptom onset

COVID-19 Antigenemia

Upper respiratory track E gene(Kogene kit)

Lower respiratory track E gene (Kogene kit)

Positive

Negative

Total

Sensitivity

Positive

Negative

Total

Sensitivity

Positive

Negative

Total

Sensitivity

 − 3 to 0

17

6

23

73.9

9

2

11

81.8

9

0

9

100.0

1 to 3

29

4

33

87.9

14

1

15

93.3

8

2

10

80.0

4 to 6

18

9

27

66.7

17

4

21

80.9

9

5

14

64.3

7 to 9

35

13

48

72.9

11

6

17

64.7

13

1

14

92.9

10 to 12

21

9

30

70.0

14

2

16

87.5

6

7

13

46.2

13 to 15

28

13

41

68.3

10

3

13

76.9

8

4

12

66.7

16 to

20

37

57

35.1

16

38

54

29.6

22

31

53

41.5

  1. Samples were segregated from the admission date with 3 days interval until 16 + days; cycle threshold (cutoff) of 35; Ct-35 was used according to the manufacturer’s instructions. Nasopharyngeal and lower respiratory tract sputum samples were collected from the upper respiratory tract.